Normal view MARC view ISBD view

Reversal of theophylline toxicity using oral activated charcoal. [electronic resource]

By:

Davis, R

Contributor(s):

Producer: 19850214Description: 73-4 p. digitalISSN:

0094-3509

Subject(s):

In: The Journal of family practice vol. 20

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Case Reports; Journal Article

There are no comments on this title.

to post a comment.

Back to results

4561 Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
by Yoshikawa, Takaki
4562 The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer.
by Hsieh, Ming-Yu
4563 Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer.
by Yang, Honglan
4564 Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer.
by Tsuchiya, Tomoshi
4565 Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.
by Kosaka, Takashi
4566 Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
by Wei, J
4567 An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer.
by Kaira, Kyoichi
4568 Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1.
by Morimoto, Yoshihito
4569 Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
by Tsujii, H
4570 [Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy].
by Terasawa, T
4571 [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
by Niimoto, M
4572 [Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies].
by Tsukagoshi, S
4573 Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer.
by Koinumaru, S
4574 [Chemotherapy of gastric cancer--a review of clinical trials in Japan].
by Sato, Atsushi
4575 [A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
by Akiba, Yasutada
4576 Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
by Ishikawa, T
4577 [Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
by Fujimori, Shigeru
4578 Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
by Kawai, Hiroki
4579 [A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
by Ishikawa, Tetsuro
4580 What's new in pancreatic cancer treatment pipeline?
by Von Hoff, Daniel D